WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback